CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-30 | SCHIMMEL PAUL Director | Purchase | +89,275 | $0.76 | $67K | 692,328 |
| 2018-08-29 | SCHIMMEL PAUL Director | Purchase | +75,136 | $0.72 | $54K | 603,053 |
| 2018-07-30 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2018-05-31 | Amanullah Ashraf See Remarks | Option exercise | +3,333 | 26,264 | ||
| 2018-05-31 | Amanullah Ashraf See Remarks | Option exercise · Restricted Stock Units | +3,333 | 3,333 | ||
| 2018-05-18 | SCHIMMEL PAUL Director | Purchase | +150,000 | $1.00 | $149K | 527,917 |
| 2018-05-16 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Sale | −2,733,231 | $0.81 | $2.2M | 0 |
| 2018-05-15 | SCHIMMEL PAUL Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-05-15 | Nashat Amir Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-05-15 | MENDLEIN JOHN Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-05-15 | Hatfield Jeffrey S. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-05-15 | Coughlin Timothy P Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-05-15 | CLARKE JOHN K Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-05-15 | BLAIR JAMES C Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-05-15 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Sale | −121,294 | $1.43 | $173K | 2,733,231 |
| 2018-05-14 | EcoR1 Capital Fund Qualified, L.P. 10% owner | Sale | −354,791 | $1.72 | $609K | 2,854,525 |
| 2018-02-08 | Blake John T Senior Vice President, Finance | Sale | −1,402 | $3.40 | $5K | 1,932 |
| 2018-02-08 | Amanullah Ashraf See Remarks | Sale | −1,402 | $3.40 | $5K | 1,932 |
| 2018-02-07 | Blake John T Senior Vice President, Finance | Option exercise | +3,334 | 3,334 | ||
| 2018-02-07 | Blake John T Senior Vice President, Finance | Option exercise · Restricted Stock Units | −3,334 | 6,666 |
Page 11 of 25 · 483 trades